Foamix Pharmaceuticals Ltd. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Foamix Pharmaceuticals Ltd. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $7.22 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2020-03-12
- 2019-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $7.22M.
- 2018-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $8.24M.
- 2017-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $9.34M.
- 2016-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $6.74M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2019-12-31 | $7.22M 10-K · filed 2020-03-12 |
| 2018-12-31 | $8.24M 10-K · filed 2019-02-28 |
| 2017-12-31 | $9.34M 10-K · filed 2018-03-01 |
| 2016-12-31 | $6.74M 20-F · filed 2017-02-21 |
| 2015-12-31 | $6.48M 20-F · filed 2016-03-02 |
| 2014-12-31 | $1.49M 20-F · filed 2016-03-02 |